These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10458015)

  • 1. [Interferon-alpha plus ribavirin combination therapy in chronic hepatitis C].
    Sarrazin C; Zeuzem S
    Z Gastroenterol; 1999 Jul; 37(7):669-74. PubMed ID: 10458015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic hepatitis C--therapeutic modalities for interferon failure].
    Hermann R
    Praxis (Bern 1994); 1998 Oct; 87(42):1413-20. PubMed ID: 9824949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C.
    Hoffmann RM; Berg T; Teuber G; Prümmer O; Leifeld L; Jung MC; Spengler U; Zeuzem S; Hopf U; Pape GR
    Z Gastroenterol; 1999 Aug; 37(8):715-23. PubMed ID: 10494606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is combination therapy of chronic hepatitis C with interferon alpha and ribavirin in primary interferon nonresponders indicated?--An analysis of personal experiences and review of the literature].
    Wedemeyer H; Jäckel E; Wedemeyer J; Frank H; Schüler A; Trautwein C; Manns MP
    Z Gastroenterol; 1998 Sep; 36(9):819-27. PubMed ID: 9795411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon plus ribavirin: a cautionary note.
    Macedo G; Ribeiro T
    Am J Gastroenterol; 1999 Oct; 94(10):3087-8. PubMed ID: 10520894
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C infection. Overweight virus carriers are more difficult to cure].
    MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)].
    Juszczyk J; Bolewska B; Flieger J; Swietek K; Adamek B; Biskupska-Karasińska M; Dziambor AP; Boroń-Kaczmarska A; Wawrzynowicz-Syczewska M; Cianciara J; Kozłowska J; Daniluk J; Słomka M; Dudziak M; Zaborowski P; Gładysz A; Piszko P; Gonciarz Z; Mazur W; Machniak M; Kryczka W; Zarebska-Michaluk D; Trocha H; Witczak-Malinowska K; Lakomy E; Kuydowicz J; Niwicka-Michałowska A
    Pol Merkur Lekarski; 2001 Oct; 11(64):340-3. PubMed ID: 11770315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

  • 10. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
    Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
    Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous reactions to interferon and ribavirin.
    Chamberlain AJ; Poon E
    Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
    Maddrey WC
    Semin Liver Dis; 1999; 19 Suppl 1():67-75. PubMed ID: 10349694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucopenia is a side effect of combination therapy for hepatitis C infection.
    Russo F; Bacosi M; Miglioresi L; Ricci GL
    Am J Gastroenterol; 2000 Apr; 95(4):1100-1. PubMed ID: 10763981
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.
    Miura Y; Kami M; Yotsuya R; Toda N; Komatsu T
    Am J Hematol; 2008 Sep; 83(9):758-9. PubMed ID: 18615552
    [No Abstract]   [Full Text] [Related]  

  • 16. An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C.
    Tinè F; Graviano D; Giannuoli G; Madonia S; Malizia G; Patti S; Fasola S; Cottone M; D'Amico G;
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1113-23. PubMed ID: 20848397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The uncertain natural history of thyrotoxic patients treated with combination interferon alfa-2beta and ribavirin.
    Tran HA
    Arch Intern Med; 2005 May; 165(9):1072; author reply 1072-3. PubMed ID: 15883255
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ribavirin/interferon-alpha combination in treatment of chronic hepatitis C: what is the status today?].
    Renner EL
    Schweiz Med Wochenschr; 1999 Jan; 129(1-2):8-10. PubMed ID: 10065494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].
    Chebil A; Kort F; Bouraoui R; Youssef NB; El Matri L
    J Fr Ophtalmol; 2010 Mar; 33(3):185-8. PubMed ID: 20172621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male periconceptional ribavir-ininterferon alpha-2b exposure with no adverse fetal effects.
    Bianca S; Ettore G
    Birth Defects Res A Clin Mol Teratol; 2003 Jan; 67(1):77-8. PubMed ID: 12749388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.